Kuros Biosciences AG
SIX:KURN
Kuros Biosciences AG
Cash from Financing Activities
Kuros Biosciences AG
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Kuros Biosciences AG
SIX:KURN
|
Cash from Financing Activities
-CHf171k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
ADC Therapeutics SA
NYSE:ADCT
|
Cash from Financing Activities
$73.9m
|
CAGR 3-Years
-47%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
AC Immune SA
NASDAQ:ACIU
|
Cash from Financing Activities
CHf43.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-17%
|
CAGR 10-Years
N/A
|
|
CRISPR Therapeutics AG
NASDAQ:CRSP
|
Cash from Financing Activities
$62.7m
|
CAGR 3-Years
-60%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
N/A
|
|
Basilea Pharmaceutica AG
SIX:BSLN
|
Cash from Financing Activities
-CHf57.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-57%
|
CAGR 10-Years
-20%
|
|
Idorsia Ltd
SIX:IDIA
|
Cash from Financing Activities
CHf162.3m
|
CAGR 3-Years
396%
|
CAGR 5-Years
-31%
|
CAGR 10-Years
N/A
|
See Also
What is Kuros Biosciences AG's Cash from Financing Activities?
Cash from Financing Activities
-171k
CHF
Based on the financial report for Dec 31, 2023, Kuros Biosciences AG's Cash from Financing Activities amounts to -171k CHF.